DE69831808D1 - Behandlung der diabetes mit thiazolidindione, insulin sekretionförderer und biguanide - Google Patents

Behandlung der diabetes mit thiazolidindione, insulin sekretionförderer und biguanide

Info

Publication number
DE69831808D1
DE69831808D1 DE69831808T DE69831808T DE69831808D1 DE 69831808 D1 DE69831808 D1 DE 69831808D1 DE 69831808 T DE69831808 T DE 69831808T DE 69831808 T DE69831808 T DE 69831808T DE 69831808 D1 DE69831808 D1 DE 69831808D1
Authority
DE
Germany
Prior art keywords
thiazolideindione
biguanides
diabetes
treatment
insulin secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69831808T
Other languages
English (en)
Other versions
DE69831808T2 (de
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69831808D1 publication Critical patent/DE69831808D1/de
Publication of DE69831808T2 publication Critical patent/DE69831808T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE69831808T 1997-07-18 1998-07-16 Behandlung der diabetes mit thiazolidindione, insulinsekretionförderer und big uanide Expired - Fee Related DE69831808T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
GB9715295 1997-07-18
PCT/GB1998/002110 WO1999003477A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Publications (2)

Publication Number Publication Date
DE69831808D1 true DE69831808D1 (de) 2006-02-16
DE69831808T2 DE69831808T2 (de) 2006-07-06

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831808T Expired - Fee Related DE69831808T2 (de) 1997-07-18 1998-07-16 Behandlung der diabetes mit thiazolidindione, insulinsekretionförderer und big uanide

Country Status (40)

Country Link
EP (1) EP1001783B1 (de)
JP (2) JP2001510159A (de)
KR (1) KR100671918B1 (de)
CN (1) CN1264303A (de)
AP (1) AP1352A (de)
AR (1) AR016349A1 (de)
AT (1) ATE305790T1 (de)
AU (1) AU8448898A (de)
BG (1) BG64785B1 (de)
BR (1) BR9810445A (de)
CA (1) CA2296653C (de)
CO (1) CO4940420A1 (de)
CY (1) CY1105254T1 (de)
DE (1) DE69831808T2 (de)
DK (1) DK1001783T3 (de)
DZ (1) DZ2562A1 (de)
EA (1) EA003021B1 (de)
ES (1) ES2251093T3 (de)
GB (1) GB9715295D0 (de)
HK (1) HK1028550A1 (de)
HU (1) HUP0003629A3 (de)
ID (1) ID24211A (de)
IL (1) IL134046A0 (de)
IN (1) IN189275B (de)
MA (1) MA24607A1 (de)
MY (1) MY155219A (de)
NO (1) NO325727B1 (de)
NZ (2) NZ501164A (de)
OA (1) OA11279A (de)
PE (1) PE99599A1 (de)
PL (2) PL198017B1 (de)
SA (1) SA98190468B1 (de)
SI (1) SI1001783T1 (de)
SK (1) SK285484B6 (de)
TR (1) TR200000134T2 (de)
TW (1) TW505516B (de)
UA (1) UA70303C2 (de)
UY (1) UY25102A1 (de)
WO (1) WO1999003477A1 (de)
ZA (1) ZA986363B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
SK287038B6 (sk) * 1998-11-12 2009-10-07 Smithkline Beecham Plc Farmaceutický prostriedok na postupné uvoľňovanie 5-[4-[2-(N- metyl-N-(2-pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu a metformínu a spôsob jeho výroby
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
JP2003514011A (ja) * 1999-11-16 2003-04-15 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
MXPA04000180A (es) * 2001-07-10 2004-11-22 Kos Life Sciences Inc Formulacion de nucleo que comprende hidrocloruro de pioglitazona y una biguanida.
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
NZ546337A (en) 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
JP7005050B2 (ja) 2017-10-20 2022-01-21 ノブメタファーマ カンパニー リミテッド 亜鉛塩、シクロ－ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
DK0601001T3 (da) * 1991-08-26 1997-10-20 Upjohn Co Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EA003025B1 (ru) * 1997-06-18 2002-12-26 Смитклайн Бичам Плс Лечение диабета тиазолидиндионом и сульфонилмочевиной

Also Published As

Publication number Publication date
TW505516B (en) 2002-10-11
DZ2562A1 (fr) 2003-02-15
CN1264303A (zh) 2000-08-23
MA24607A1 (fr) 1999-04-01
EA200000139A1 (ru) 2000-06-26
CA2296653A1 (en) 1999-01-28
JP2001510159A (ja) 2001-07-31
HK1028550A1 (en) 2001-02-23
AR016349A1 (es) 2001-07-04
CY1105254T1 (el) 2010-03-03
HUP0003629A3 (en) 2003-04-28
IL134046A0 (en) 2001-04-30
ATE305790T1 (de) 2005-10-15
DK1001783T3 (da) 2006-02-06
UA70303C2 (uk) 2004-10-15
ID24211A (id) 2000-07-13
SA98190468B1 (ar) 2007-01-20
EA003021B1 (ru) 2002-12-26
PL338126A1 (en) 2000-09-25
SK592000A3 (en) 2000-09-12
KR100671918B1 (ko) 2007-01-22
EP1001783A1 (de) 2000-05-24
JP2005213273A (ja) 2005-08-11
NZ511608A (en) 2002-12-20
KR20010021947A (ko) 2001-03-15
HUP0003629A2 (hu) 2001-07-30
GB9715295D0 (en) 1997-09-24
ES2251093T3 (es) 2006-04-16
NO20000228L (no) 2000-01-17
AP2000001733A0 (en) 2000-03-31
AP1352A (en) 2004-12-24
DE69831808T2 (de) 2006-07-06
TR200000134T2 (tr) 2000-09-21
NO20000228D0 (no) 2000-01-17
NO325727B1 (no) 2008-07-07
SK285484B6 (sk) 2007-02-01
CA2296653C (en) 2007-10-02
BG104135A (en) 2000-10-31
EP1001783B1 (de) 2005-10-05
BR9810445A (pt) 2000-09-05
WO1999003477A1 (en) 1999-01-28
ZA986363B (en) 2000-01-17
BG64785B1 (bg) 2006-04-28
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
PL198017B1 (pl) 2008-05-30
PE99599A1 (es) 1999-12-18
AU8448898A (en) 1999-02-10
NZ501164A (en) 2001-06-29
IN189275B (de) 2003-01-25
UY25102A1 (es) 2000-12-29
CO4940420A1 (es) 2000-07-24
OA11279A (en) 2003-07-31
MY155219A (en) 2015-09-30

Similar Documents

Publication Publication Date Title
DE69831808D1 (de) Behandlung der diabetes mit thiazolidindione, insulin sekretionförderer und biguanide
ATE355840T1 (de) Behandlung der diabetes mit thiazolidindione und metformin
DE69316751T2 (de) Azlaktonfunktionen aufweisende substrate, hornhautprothesen und ihre verwendung
FI963482A0 (fi) Menetelmä hematopoieesin stimuloimiseksi hemoglobiinilla
DE69107919D1 (de) Feuchtigkeitsabsorbierender, stellenoffenlegender Klebeverband.
PH23014A (en) Novel insulin derivatives,their use and pharmaceutical agents for the treatment of diabetes mellitus
FI964314A (fi) Substituoidut sulfonamidit selektiivisinä beta3-agonisteina diabeteksen ja liikalihavuuden hoitoon
EE9900345A (et) Sulfonüülkarbamiidi ja glitasooni sünergistilised kombinatsioonid diabeedi raviks
IT1293690B1 (it) Stent per angioplastica, particolarmente per il trattamento di lesioni aorto-ostiali ed ostiali.
ATE292975T1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
DE3873992D1 (de) Blutfetterniedrigende und antiatherosclerotische harnstoff-verbindungen.
IS5275A (is) Meðhöndlun á insúlín viðnámi með vaxtarhormóna seyti
NO912664L (no) Medisinsk kollagent adhesiv og dets anvendelse.
ATE202782T1 (de) Optisch-aktives benzothiepin-derivate, ihre herstellung und verwendung
DE69837089D1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
ATE366577T1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
DE60012671D1 (de) Zahnriemen mit Klebstofzusammensetzung behandelten Zahnabdeckgewebe
ATE554787T1 (de) Behandlung von typ-1-diabetes vor und nach der expression von prädispositionsmarkern
ATE92743T1 (de) Klebverbaende, ihre herstellung und anwendung.
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
IT9048035A1 (it) Assorbente mutandina usa e getta con trattamento batteriostatico, fungostatico e antibatterico
DE69100027D1 (de) Traeger fuer therapeutische, aeusserlich anwendbare wirkstoffe sowie diesen traeger enthaltendes antiseptikum.
SE9401089D0 (sv) Elastisk, cirkulär kropp för spänning av drivremmar o.l.
DE69727827T2 (de) Verwendung von 2-(2-morpholinophenyl)guanidinderivate zur behandlung von diabetes-komplikationen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee